ZHAI Xiaobo, WANG Yamin, BAI Rong, HE Zhigao. Clinical pharmacists in promoting the rational use of angiotensin-converting enzyme inhibitors in the CCU[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(5): 472-474,478. doi: 10.3969/j.issn.1006-0111.2017.05.022
| Citation:
|
ZHAI Xiaobo, WANG Yamin, BAI Rong, HE Zhigao. Clinical pharmacists in promoting the rational use of angiotensin-converting enzyme inhibitors in the CCU[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(5): 472-474,478. doi: 10.3969/j.issn.1006-0111.2017.05.022
|
Clinical pharmacists in promoting the rational use of angiotensin-converting enzyme inhibitors in the CCU
-
Department of Pharmacy, Shanghai East Hospital Affiliated to Tongji University, Shanghai 200120, China
- Received Date: 2016-06-02
- Rev Recd Date:
2017-05-17
-
Abstract
Objective To improve the rational use of angiotensin-converting enzyme inhibitors (ACEI). Methods Clinical pharmacists reviewed ACEI use for the patients admitted into coronary heart disease care unit (CCU) during May 2012 to May 2013 to analyze the rational use of ACEI according to the expert consensus standards, guidelines and drug instructions of ACEI without any interventions. Clinical pharmacists intervened the irrational use of ACEI based on the same standard from June 2013 to May 2015. Results By comparing the data before and after intervention, it was found that the percentage of ACEI use increased from 80.1% to 98.9%. The percentage of initial ACEI overdose was dropped from 21.4% to 0.9%, and the percentage of under dose was decreased from 4.7% to 0.5%, which was statistically significant. Conclusion Clinical pharmacists can play a leading role in promoting the rational use of ACEI.
-
References
|
[1]
|
陈盛新,栾智鹏. 药物治疗与病人保健［J］. 药学实践杂志,2009,27(1):73-77. |
|
[2]
|
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 慢性收缩性心力衰竭治疗建议［J］. 中华心血管病杂志,2002,30(1):7-23. |
|
[3]
|
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会, 中国循环杂志编辑委员会. 急性心肌梗死诊断和治疗指南［J］. 中华心血管病杂志,2001,29(12):710-725. |
|
[4]
|
Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report［J］. JAMA,2003,289(19):2560-2572. |
|
[5]
|
Cheng J, Zhang W, Zhang X,et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis［J］.JAMA Intern Med, 2014,174(5):773-85. |
|
[6]
|
Sandra SA, Elizabeth L, Lopez C. Intervention to improve adherence to ACC/AHA recommended adjunctive medications for the management of patients with an acute myocardial infarction［J］. Clin Cardiol, 2001,24:114-118. |
|
[7]
|
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 血管紧张素转化酶抑制剂在心血管病中应用中国专家共识［J］. 中华心血管杂志,2007,35(2):97-106. |
|
[8]
|
翟晓波,朱 珺. 智能化和精确化用药监测软件的研发及应用［J］. 中国现代应用药学. 2010,27(4):361-366. |
|
[9]
|
张晓荧,张四喜,周 微,等. 肾内科临床药师在药物整合服务中的实践探索［J］. 药学实践杂志,2015,33(1):88-90. |
-
-
Proportional views
-
DownLoad: